Manufactured by: Incepta Pharmaceuticals Ltd.
Medroxyprogesterone Acetate Similar medicine
El sangrado intermenstrual puede ocurrir en personas que reciben tratamiento para la endometriosis. Este tratamiento también puede causar cierta retención de líquidos, por lo que se debe vigilar cuidadosamente a los pacientes con afecciones como epilepsia, migraña, asma, problemas cardíacos o renales. Algunas personas también pueden tener una tolerancia reducida a la glucosa. Se debe vigilar de cerca a las personas con depresión, diabetes, epilepsia, asma, migraña, presión arterial alta o problemas renales o cardíacos. Esté atento a signos de cambios en la visión, problemas oculares y coágulos de sangre. Tenga cuidado si la paciente está amamantando.
La aminoglutetimida y ciertos medicamentos que aumentan la actividad enzimática (como carbamazepina, griseofulvina, fenobarbital, rifampicina y fenitoína) pueden reducir la cantidad del medicamento en la sangre, haciéndolo menos efectivo. Si se usa medroxiprogesterona como método anticonceptivo junto con estos medicamentos, es posible que se necesiten precauciones adicionales o métodos anticonceptivos adicionales.
- Trastornos de los coágulos sanguíneos
- Accidente cerebrovascular
- Problemas hepáticos graves
- aborto espontáneo incompleto
- Cánceres relacionados con hormonas
- Sangrado vaginal inexplicable
- Sangrado inexplicable del tracto urinario.
- Embarazo conocido o posible
- Problemas mamarios inexplicables
- aborto espontáneo perdido
- Coágulos sanguíneos activos
- Problemas hepáticos graves
La medroxiprogesterona es una hormona sintética similar a la progesterona. Cambia el revestimiento del útero de la fase de crecimiento a la fase secretora. Si bien tiene algunas acciones débiles similares a las hormonas masculinas (andrógenos) y promueve la construcción de tejido (efectos anabólicos), no actúa como el estrógeno. Cuando se administra mediante inyección, bloquea la liberación de ciertas hormonas de la glándula pituitaria, lo que impide que los óvulos maduren y se liberen de los ovarios.
Adulto: Menorragia VO 2,5-10 mg/día durante 5-10 días en los días 16-21 del ciclo menstrual. Repita durante 2 ciclos.
Endometriosis leve a moderada 10 mg 3 veces/día durante 90 días consecutivos, comenzando el primer día del ciclo menstrual.
Como componente progestágeno en la TRH menopáusica. La dosis depende del componente estrógeno de la terapia y se utilizan varios regímenes: 1,5 mg, 2,5 mg o 5 mg/día; 5 o 10 mg/día durante 12 a 14 días de un ciclo de 28 días; 20 mg/día durante 14 días de un ciclo de 91 días.
Sangrado uterino anormal debido a desequilibrio hormonal en ausencia de patología orgánica: a partir del día 16 o 21 calculado del ciclo menstrual, se pueden administrar 5 o 10 mg de acetato de medroxiprogesterona diariamente durante 5 a 10 días.
Reducción de la hiperplasia endometrial en mujeres posmenopáusicas que reciben 0,625 mg diarios de estrógenos conjugados: las tabletas de acetato de medroxiprogesterona se pueden administrar en dosis de 5 o 10 mg diarios durante 12 a 14 días consecutivos por mes, en mujeres posmenopáusicas que reciben 0,625 mg diarios de estrógenos conjugados, ya sea comenzando el primer día del ciclo o el día 16 del ciclo.
Cáncer de mama 0,4-1,5 g/día. Máximo: 2 g/día.
Paliación del carcinoma de endometrio y renal 200-600 mg/día.
Paliación del carcinoma de próstata 100-600 mg/día.
Amenorrea secundaria 5-10 mg/día durante 5-10 días. Repita durante 3 ciclos.
Este medicamento no debe usarse durante el embarazo. Puede absorberse a través de la piel y los pulmones y puede dañar los órganos del feto y causar discapacidades congénitas. Dos tipos estrictos de control de la natalidad eficaces comienzan un mes antes y durante el tratamiento y durante tres años después de suspender este medicamento. Hable con sus médicos si no está segura de qué tipos de anticonceptivos son efectivos para usted. Debe necesitar hacerse pruebas de embarazo regularmente durante su tratamiento con este medicamento y durante al menos tres años después de tomar este medicamento. Si parece que queda embarazada, deje de tomar este medicamento y llame a su médico inmediatamente. Si realmente queda embarazada, pierde un período menstrual o tiene relaciones sexuales sin usar dos métodos anticonceptivos. En algunos casos, su médico puede recetarle anticonceptivos de emergencia para prevenir el embarazo. Las personas que toman este medicamento no deben donar sangre durante el tratamiento ni durante los tres años posteriores.
Este medicamento también está contraindicado en la leche materna. No se recomienda amamantar mientras se usa este medicamento y durante los tres años posteriores.
Price : ৳
Manufactured by: Incepta Pharmaceuticals Ltd.
Manufactured by: Nuvista Pharma Ltd
Manufactured by: Incepta Pharmaceuticals Ltd.
Manufactured by: Popular Pharmaceuticals Ltd.
Manufactured by: Incepta Pharmaceuticals Ltd.
Manufactured by: Renata Limited
Click here to see 8 more similar medicines
There are few similar medicines of Medogen are manufactured by other companies using the same ingredients. Although, it would be good if you are able to use the same medicine, which has been prescribed by your Doctor. Due to availability in the local market, you can try others. Please make sure and contact your Doctor first about alternatives.
Levonorgestrel is indicated for Contraception , Emergency contraception , Menopausal hormone replacement therapy , Menorrhagia,
List of medicines using Levonorgestrel
Mefenamic Acid is indicated for Rheumatoid arthritis, Osteoarthritis, Dysmenorrhoea, Menorrhagia, Dental pain, Pain and inflammation, Mild to moderate pain, Postoperative pain
List of medicines using Mefenamic Acid
Norethisterone is indicated for Breast cancer, Metropathia haemorrhagica (dysfunctional uterine bleeding), Premenstrual syndrome, Contraception, Endometriosis, Menorrhagia, Menopausal HRT
List of medicines using Norethisterone
Norgestrel is indicated for Contraception, Menorrhagia, Menopausal HRT
List of medicines using Norgestrel
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Levonorgestrel is indicated for Contraception , Emergency contraception , Menopausal hormone replacement therapy , Menorrhagia,
List of medicines using Levonorgestrel
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate
Medroxyprogesterone Acetate is indicated for Menorrhagia, endometriosis, menopausal HRT, breast cancer, endometrial and renal carcinoma, prostatic carcinoma, secondary amenorrhoea, contraception, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, to reduce the incidence of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets
List of medicines using Medroxyprogesterone Acetate